SEARCH

SEARCH BY CITATION

References

  • 1
    Kim T,Giuliano AE,Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma. Cancer 2006; 106: 416.
  • 2
    Wilson LL,Giuliano AE. Sentinel lymph node mapping for primary breast cancer. Curr Oncol Rep 2005; 7: 1217.
  • 3
    Ferrari A,Rovera F,Dionigi P,Limonta G,Marelli M,Besana Ciani I,Bianchi V,Vanoli C,Dionigi R. Sentinel lymph node biopsy as the new standard of care in the surgical treatment for breast cancer. Expert Rev Anticancer Ther 2006; 6: 150315.
  • 4
    Mabry H,Giuliano AE. Sentinel node mapping for breast cancer: progress to date and prospects for the future. Surg Oncol Clin N Am 2007; 16: 5570.
  • 5
    Brogi E,Torres-Matundan E,Tan LK,Cody HS. The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: a study in 133 breast cancer patients. Ann Surg Oncol 2005; 12: 17380.
  • 6
    Dowlatshahi K,Fan M,Anderson JM,Bloom KJ. Occult metastases in sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol 2001; 8: 67581.
  • 7
    Tanis PJ,Boom RP,Koops HS,Faneyte IF,Peterse JL,Nieweg OE,Rutgers EJ,Tiebosch AT,Kroon BB. Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol 2001; 8: 2226.
  • 8
    Van Diest PJ,Torrenga H,Borgstein PJ,Pijpers R,Bleichrodt RP,Rahusen FD,Meijer S. Reliability of intra-operative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology 1999; 35: 1418.
  • 9
    Torrenga H,Rahusen FD,Meijer S,Borgstein PJ,van Diest PJ. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin. Pathol. 2001; 54: 5502.
  • 10
    Van Diest PJ,Torrenga H,Meijer S,Meijer CJ. Pathologic analysis of sentinel lymph nodes. Semin Surg Oncol 2001; 20: 23845.
  • 11
    Cserni G,Amendoeira I,Apostolikas N,Bellocq JP,Bianchi S,Bussolati G,Boecker W,Borisch B,Connolly CE,Decker T,Dervan P,Drijkoningen M, et al. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 2003; 39: 165467.
  • 12
    Weigelt B,Verduijn P,Bosma A,Rutgers EJ,Peterse HL,Van't Veer LJ. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers. Br J Cancer 2004; 90: 15317.
  • 13
    Gillander WE,Mikhitarian K,Hebert R,Mauldin P,Palesch Y,Walters C,Urist M. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg 2004; 239: 82837; discussion 837–40.
  • 14
    Abdul-Rasool S,Kidson SH,Panieri E,Dent D,Pillay K,Hanekom GS. An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes. J Clin Pathol 2006; 59: 28997.
  • 15
    Chu PG,Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002; 40: 40339.
  • 16
    Horibe D,Ochiai T,Shimada H,Tomonaga T,Nomura F,Gun M,Tanizawa T,Hayashi H. Rapid detection of metastasis of gastric cancer using reverse transcription loop-mediated isothermal amplification. Int J Cancer 2006; 120: 10639.
  • 17
    Taniyama K,Motoshita J,Sakane J,Makita K,Akai Y,Daito M,Otomo Y,Ono H,Mizunoe T,Takeuchi Y,Tominaga H,Koseki M. Combination analysis of a whole lymph node by one-step nucleic acid amplification and histology for intraoperative detection of micrometastasis. Pathobiology. 2006; 73: 18391.
  • 18
    Tsujimoto M,Nakabayashi K,Yoshidome K,Kanedo T,Iwase T,Akiyama F,Kato Y,Tsuda H,Ueda S,Sato K,Tamaki Y,Noguchi S, et al. One-step nucleic acid amplification (OSNA) for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Can Res 2007; 13: 480716.
  • 19
    Singletary SA,Greene FL,Breast Task Force. Revision of breast cancer staging: The 6th edition of the TNM classification. Semin Surg Oncol 2003; 21: 5359.
  • 20
    Giettema HA,Vuylsteke RJCLM,De Jonge IA,Van Leeuwen PAM,Molenkamp BG,Van der Sijp JRM,Meijer S,Van Diest PJ. Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 2004; 57: 61820.
  • 21
    SobinLH,WittekindC, eds. UICC: TNM classification of malignant tumours,6th edn. New York: Wiley, 2002.
  • 22
    Notomi T,Okayama H,Masubuchi H,Yonekawa T,Watanabe K,Amino N,Hase T. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2000; 28: e63.
  • 23
    Mori Y,Nagamine K,Tomita N,Notomi T. Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation. Biochem Biophys Res Commun 2001; 289: 1504.
  • 24
    Cserni G,Bianchi S,Boecker W,Decker T,Lacerda M,Rank F,Wells C. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer 2005; 103: 35867.
  • 25
    Lannin D. How many breast cancer cells in a sentinel lymph node are OK. Ann Surg Oncol 2004; 11: 5534.
  • 26
    Lyman GH,Giuliano AE,Somerfield MR,Benson AB,III,Bodurka DC,Burstein HJ,Cochran AJ,Cody HS,III,Edge SB,Galper S,Hayman JA,Kim TY, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23: 770320.
  • 27
    Yun K,Gunn J,Merrie AEH,Phillips LV,McCall JL. Keratin 19 mRNA is detectable by RT-PCR in lymph nodes of patients without breast cancer. Br J Cancer 1997; 76: 111213.
  • 28
    Bostick PJ,Chatterjee S,Chi DD,Huynh KT,Giuliano AE,Cote R,Hoon D. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 1998; 16: 263240.
  • 29
    Merrie AEH,Yun K,Gunn J,Philipps LV,McCall JL. Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer. Br J Cancer 1999; 80: 201924.